MBX Biosciences (MBX) Financials: Revenue & Earnings

MBX price $53.14 +0.17 +0.32%

Ticker
MBX
Price
$53.14
Change
+0.17 +0.32%
Market cap ?
$2.56B
P/E ?
-20.21
Dividend yield ?
0.00%
Beta ?
0.10
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
63
Value
42
Quality
46
Growth
100

Stocklytics score rationale: value 42, quality 46, growth 100.

Financials

2022202320242025
0000

MBX Biosciences, Inc. is a biopharmaceutical company in its clinical development phase, dedicated to pioneering precise peptide-based therapies for endocrine and metabolic conditions. Its most advanced drug candidate, MBX 2109, is a parathyroid hormone peptide prodrug currently in Phase 2 clinical trials. This medication is being evaluated as a long-duration hormone replacement treatment for individuals suffering…

Fair value

MBX fair value Not meaningful. Price $53.14.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare MBX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.83——
2026-08-06-0.78-0.63——
2026-05-07-0.51-0.62——
2026-03-12-0.49-0.64——
2025-11-06-0.63-0.73——
2025-08-07-0.58-0.77——
2025-05-12-0.71-0.81——
2025-03-17-0.47-0.59——
2024-11-07-2.78-2.72——
2024-09-13————
2024-08-23-11.47———
2023-12-31-0.26———
2023-09-30-0.32———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-20Radovich PeterBuy18.20K$53.50973.70K
2026-10-20Radovich PeterOther0——
2026-08-04Azoulay SalomonSell370$65.7724.33K
2026-08-03Smither John WBuy130.00K$64.418.37M
2026-08-03Smither John WBuy28.00K——
2026-08-03Hoerter Steven L.Buy331.00K$64.4121.32M
2026-08-03Hoerter Steven L.Buy71.00K——
2026-06-04Mathers Edward TBuy12.50K$30.91386.38K
2026-06-04Pescovitz Ora H.Buy12.50K$30.91386.38K
2026-06-04Heron Patrick JBuy12.50K$30.91386.38K
2026-06-04Stelzer LaurieBuy12.50K$30.91386.38K
2026-06-04Hoerter Steven L.Buy12.50K$30.91386.38K
2026-06-04Ryder StevenBuy12.50K$30.91386.38K
2026-06-04Aynechi TibaBuy12.50K$30.91386.38K
2026-05-08Azoulay SalomonBuy55.00K$10.46575.30K
2026-05-08Azoulay SalomonBuy55.00K$10.46575.30K
2026-05-08Azoulay SalomonBuy15.00K$16.00240.05K
2026-05-08Azoulay SalomonBuy15.00K$16.00240.05K
2026-05-08Azoulay SalomonSell15.00K$38.30574.61K
2026-05-08Azoulay SalomonSell55.00K$38.382.11M
2026-05-06Azoulay SalomonSell231$29.546.82K
2026-05-06Hawryluk P. KentSell607$29.5417.93K
2026-05-01Hoerter Steven L.Buy74.25K$29.782.21M
2026-05-01Hoerter Steven L.Buy11.94K——
2026-03-16Smither John WOther0——
2026-03-13Hawryluk P. KentBuy18.50K$28.41525.66K
2026-02-26Hawryluk P. KentBuy28.77K$16.00460.29K
2026-02-26Hawryluk P. KentSell28.77K$16.00460.29K
2026-02-02Azoulay SalomonBuy70.00K$39.072.73M
2026-02-02Azoulay SalomonBuy15.00K——
2026-02-02Bartram RichardBuy70.00K$39.072.73M
2026-02-02Bartram RichardBuy15.00K——
2026-02-02Hawryluk P. KentBuy35.25K——
2026-02-02Hawryluk P. KentBuy164.50K$39.076.43M
2026-01-20Stelzer LaurieBuy32.00K$43.141.38M
2026-01-20Stelzer LaurieOther0——
2025-11-22Hoerter Steven L.Buy0$27.080
2025-11-22Hoerter Steven L.Buy8.00K$27.08216.64K
2025-11-06Hoerter Steven L.Buy33.75K$24.74835.00K
2025-11-06Hoerter Steven L.Buy100.00K$24.742.47M
2025-10-24Hawryluk P. KentBuy182.86K$3.25594.29K
2025-10-24Hawryluk P. KentSell182.86K$3.25594.29K
2025-10-20Hawryluk P. KentBuy20.00K$13.64272.79K
2025-10-17Hoerter Steven L.Buy20.00K$13.25264.98K
2025-09-26Heron Patrick JBuy666.67K$18.0012.00M
2025-06-05Mathers Edward TBuy16.00K$11.86189.76K
2025-06-05Hoerter Steven L.Buy16.00K$11.86189.76K
2025-06-05Aynechi TibaBuy16.00K$11.86189.76K
2025-06-05CORNELIUS JAMES MBuy16.00K$11.86189.76K
2025-06-05Ryder StevenBuy16.00K$11.86189.76K
2025-06-05Heron Patrick JBuy16.00K$11.86189.76K
2025-06-05Pescovitz Ora H.Buy16.00K$11.86189.76K
2025-04-08Pescovitz Ora H.Buy7.69K$5.8945.31K
2025-04-07Hoerter Steven L.Buy32.00K$6.00192.00K
2025-04-07Hoerter Steven L.Other0——
2025-02-18GORDON CARL LBuy49.07K$10.84531.92K
2025-02-18GORDON CARL LBuy94.10K$10.841.02M
2025-02-18ORBIMED ADVISORS LLCBuy49.07K$10.84531.92K
2025-02-18ORBIMED ADVISORS LLCBuy94.10K$10.841.02M
2025-02-14GORDON CARL LBuy29.54K$9.85290.97K
2025-02-14GORDON CARL LBuy17.96K$9.90177.82K
2025-02-14ORBIMED ADVISORS LLCBuy29.54K$9.85290.97K
2025-02-14ORBIMED ADVISORS LLCBuy17.96K$9.90177.82K
2025-02-04Hawryluk P. KentBuy50.00K$10.69534.50K
2025-02-03Azoulay SalomonBuy90.00K$10.49944.10K
2025-02-03Bartram RichardBuy95.00K$10.49996.55K
2025-02-03Hawryluk P. KentBuy243.00K$10.492.55M
2024-09-16Mathers Edward TBuy500.00K$16.008.00M
2024-09-16Mathers Edward TBuy2.09M——
2024-09-16Mathers Edward TBuy1.02M——
2024-09-16Mathers Edward TSell12.30M——
2024-09-16Mathers Edward TSell25.14M——
2024-09-16BASKETT FORESTBuy500.00K$16.008.00M
2024-09-16BASKETT FORESTBuy2.09M——
2024-09-16BASKETT FORESTBuy1.02M——
2024-09-16BASKETT FORESTSell12.30M——
2024-09-16BASKETT FORESTSell25.14M——
2024-09-16Behbahani AliBuy500.00K$16.008.00M
2024-09-16Behbahani AliBuy2.09M——
2024-09-16Behbahani AliBuy1.02M——
2024-09-16Behbahani AliSell12.30M——
2024-09-16Behbahani AliSell25.14M——
2024-09-16Chang CarmenBuy500.00K$16.008.00M
2024-09-16Chang CarmenBuy2.09M——
2024-09-16Chang CarmenBuy1.02M——
2024-09-16Chang CarmenSell12.30M——
2024-09-16Chang CarmenSell25.14M——
2024-09-16Florence Anthony A. Jr.Buy500.00K$16.008.00M
2024-09-16Florence Anthony A. Jr.Buy2.09M——
2024-09-16Florence Anthony A. Jr.Buy1.02M——
2024-09-16Florence Anthony A. Jr.Sell12.30M——
2024-09-16Florence Anthony A. Jr.Sell25.14M——
2024-09-16Makhzoumi MohamadBuy500.00K$16.008.00M
2024-09-16Makhzoumi MohamadBuy2.09M——
2024-09-16Makhzoumi MohamadBuy1.02M——
2024-09-16Makhzoumi MohamadSell12.30M——
2024-09-16Makhzoumi MohamadSell25.14M——
2024-09-16Walker Paul EdwardBuy500.00K$16.008.00M
2024-09-16Walker Paul EdwardBuy2.09M——
2024-09-16Walker Paul EdwardBuy1.02M——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 182, holders +21 vs prior quarter. Ownership 116.81%.

HolderSharesChangeChange %Value
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.6.65M00.00%367.19M
FMR LLC5.32M2.39M+81.25%293.82M
WELLINGTON MANAGEMENT GROUP LLP4.98M1.79M+55.95%274.76M
NEA MANAGEMENT COMPANY, LLC3.61M00.00%199.52M
ORBIMED ADVISORS LLC3.43M-209.15K-5.75%189.27M
BLACKROCK, INC.3.32M382.27K+13.00%183.47M
PARADIGM BIOCAPITAL ADVISORS LP2.51M2.51MNew138.44M
NVP ASSOCIATES, LLC2.14M00.00%117.93M
DEEP TRACK CAPITAL, LP1.73M-1.02M-37.17%95.64M
POLAR CAPITAL HOLDINGS PLC1.61M-13.67K-0.84%88.79M
VANGUARD CAPITAL MANAGEMENT LLC1.48M-204-0.01%81.55M
AARON WEALTH ADVISORS LLC1.17M-377-0.03%64.46M
DRIEHAUS CAPITAL MANAGEMENT LLC1.06M38.37K+3.77%58.32M
KYNAM CAPITAL MANAGEMENT, LP934.80K00.00%51.60M
WOODLINE PARTNERS LP900.09K29+0.00%49.69M
EVENTIDE ASSET MANAGEMENT, LLC873.49K-16.51K-1.85%48.22M
STATE STREET CORP864.47K77.26K+9.81%47.72M
PRICE T ROWE ASSOCIATES INC /MD/814.81K-214.20K-20.82%44.98M
PARKMAN HEALTHCARE PARTNERS LLC800.17K136+0.02%44.17M
GEODE CAPITAL MANAGEMENT, LLC773.07K102.69K+15.32%42.68M
BRAIDWELL LP710.88K-781.59K-52.37%39.24M
TCG CROSSOVER MANAGEMENT, LLC650.00K00.00%35.88M
CORMORANT ASSET MANAGEMENT, LP550.00K-570.00K-50.89%30.36M
SOLEUS CAPITAL MANAGEMENT, L.P.515.28K336.38K+188.03%28.44M
GOLDMAN SACHS GROUP INC459.00K1.06K+0.23%25.34M

Earnings and financials

MBX Biosciences, Inc. Common Stock (MBX) trades at $53.14, with a market cap of $2.56B and a trailing P/E of -20.21. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2022202320242025
0000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

MBX Biosciences (MBX) Financials: Revenue & Earnings

MBX$53.14+0.17 +0.32%

$2.56B

Market Cap

-20.21

P/E

—

Forward P/E

63

Score

Price History